Status:
COMPLETED
Transcranial Direct Current Stimulation and Walking in Multiple Sclerosis
Lead Sponsor:
Thorsten Rudroff
Conditions:
Transcranial Direct Current Stimulation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Weakness on one side of the body is a hallmark of Multiple Sclerosis (MS), which has been determined to be a significant cause of progressive worsening of walking abilities. Currently, there are no ef...
Detailed Description
Prospective participants, men and women with MS, will be recruited. To accomplish this study, each of the two groups of participants will need to complete 3 sessions at the INPL, each separated by 5-8...
Eligibility Criteria
Inclusion
- medically diagnosed with Multiple Sclerosis,
- moderate disability (Patient Determined Disease Steps (PDDS) core 2-6), -self-- reported differences in function between legs, able to walk for 6min. -
Exclusion
- relapse within last 60 days,
- high risk for cardiovascular disease (ACSM risk classification),
- changes in disease modifying medications within last 45 days,
- concurrent neurological/neuromuscular disease,
- hospitalization within last 90 days,
- diagnosed depression, inability to understand/sign informed consent.
Key Trial Info
Start Date :
February 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2019
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03757819
Start Date
February 25 2019
End Date
July 7 2019
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242